SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-19-074095
Filing Date
2019-12-19
Accepted
2019-12-19 08:32:15
Documents
90
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tm1919825d1_10k.htm 10-K 1635860
2 EXHIBIT 10.13 tm1919825d1_ex10-13.htm EX-10.13 7934
3 EXHIBIT 23.1 tm1919825d1_ex23-1.htm EX-23.1 3644
4 EXHIBIT 31.1 tm1919825d1_ex31-1.htm EX-31.1 10970
5 EXHIBIT 32.1 tm1919825d1_ex32-1.htm EX-32.1 4890
12 GRAPHIC tm1919825d1_10kimg001.jpg GRAPHIC 33834
  Complete submission text file 0001104659-19-074095.txt   8429136

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ons-20190930.xml EX-101.INS 1792891
7 XBRL TAXONOMY EXTENSION SCHEMA ons-20190930.xsd EX-101.SCH 79753
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ons-20190930_cal.xml EX-101.CAL 59549
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ons-20190930_def.xml EX-101.DEF 288225
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ons-20190930_lab.xml EX-101.LAB 593395
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ons-20190930_pre.xml EX-101.PRE 523581
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-37759 | Film No.: 191294196
SIC: 2836 Biological Products, (No Diagnostic Substances)